| SLB |
Report |
Adjusted EPS |
MISS |
pred ~$0.46 vs. cons $0.52 |
MEDIUM |
| SLB |
Report |
Total Revenue |
MISS |
pred ~$8.55B vs. cons $8.71B |
MEDIUM |
| SLB |
Report |
Middle East & Asia Revenue |
MISS |
pred ~$2.35B vs. cons ~$2.60B |
MEDIUM |
| SLB |
Guide |
FY2026 EPS/earnings framework (H2 recovery narrative) |
LOWER |
guide ~$2.05-2.15 FY26 vs. cons ~$2.25 (FY2026) |
MEDIUM |
| SLB |
Guide |
Q3 2026 EPS guide |
LOWER |
guide ~$0.53 vs. cons $0.58 (Q3 2026) |
LOW |
| SLB |
Guide |
2026 Shareholder Returns (buybacks+dividends) |
UNCHANGED |
guide ~$4.0B vs. cons $4.0B (FY2026) |
MEDIUM |
| SLB |
Guide |
Data Center Solutions exit run-rate |
UNCHANGED |
guide ~$1.0B exit run-rate vs. cons $1.0B (YE2026) |
MEDIUM |
| SLB |
Return |
Day-1 residual (stock − beta × S&P 500) |
-5.0% |
— |
MEDIUM |
| SLB |
Return |
5-day cumulative residual |
-7.5% (FOLLOW-THROUGH) |
HAL's Q2 print already showed Street underestimating Middle East margin damage even with in-line EPS, and SLB's own Q1 recovery assumption (mid-quarter easing) was invalidated by Qatar/Iraq force-majeure extensions through October. A Q2 EPS/margin miss paired with a cautious or reduced full-year/H2 framework should trigger sell-side model updates that cut out-quarter (Q3/Q4/FY26) EPS and FCF estimates over the following days, pulling the stock lower in follow-through fashion rather than stabilizing, since the negative revision cycle (analogous to HAL, whose stock kept sliding after initial reaction) tends to play out over multiple sessions as models are rebuilt around a longer disruption timeline. |
MEDIUM |